Marisa Miraldo is Full Professor of Health Economics at the Department of Economics and Public Policy at Imperial College Business School. She is Academic Director of the MSc in International Health Management.
Marisa’s expertise is on behavioural interventions to promote health and wellbeing and the economics and policy of healthcare innovation.
She has a track record of leading interdisciplinary research and currently leads several international projects including: the primary prevention workstream of the Global Health Research Unit (GHRU) on Diabetes and Cardiovascular Disease in South Asians, where she leads behavioural change interventions to promote better diets; the workstream on behavioural change interventions within the Jameel Institute-Kenneth C. Griffin Initiative for the Economics of Pandemic Preparedness (EPPI); and the workstream on Incentives for Innovation and Equitable access to Innovation within the Hi-Prix Consortia.
She is a fellow of Imperial College Data Science Institute and she currently serves on the academic advisory board of the Centre for Translational Nutrition and Food Research, the advisory committee of the Global Development Hub, and is a Co-Lead of the ICL Women’s Health Initiative.
Marisa is a leading advocate of Equality, Diversity and Inclusion (EDI), has chaired the EDI Committee at the Business School, founded the Gender Equity Committee at the ICBS and has been awarded a Julia Higgins Award for her contribution to EDI.
She is an award-winning educator and has led the executive education Advanced Management Programme in Health Innovation at ICL. In the past she has been Associate Head of the Department of Management at Imperial College Business School and has held academic appointments at the Centre for Health Economics and the Department of Economics and Related Studies both at the University of York.
Marisa holds a PhD in economics from York University, a MSc in Economics and Finance from Universitat Pompeu Fabra, a Master of Arts in Economics from Université Catholique de Louvain and a first degree in economics from Universidade Católica Portuguesa.
Recent public talks:
- World Economic Forum
- Where do we go from here? Leadership for Social Good
- Pay for Performance at Hospinnomics
- Harnessing Innovation for Global Health
Recent thought leadership articles and media coverage:
- How to make healthy eating easier
- Food solutions at Davos
- Can we build a culture of innovation in healthcare?
- How to give innovation a boost in healthcare
- Piloting a path for digital innovation
- New Homes for Old Drugs
Miraldo M, Gentilini A, 2023, The role of patient organisations in research and development: Evidence from rare diseases, Social Science and Medicine, Vol:338, ISSN:0277-9536
et al., 2023, Optimal hospital care scheduling during the SARS-CoV-2 pandemic, Management Science, Vol:69, ISSN:0025-1909, Pages:5923-5947
Chen J, Miraldo M, 2022, The impact of hospital price and quality transparency tools on healthcare spending: a systematic review, Health Economics Review, Vol:12, ISSN:2191-1991, Pages:1-12
et al., 2022, Correction to: The impact of the priority review voucher on research and development for tropical diseases, Pharmaceutical Medicine, Vol:36, ISSN:1178-2595, Pages:405-405
Hansen C, Miraldo M, Hauck K, 2022, Does community HIV combination prevention (HPTN 071 (PopART)) impact healthcare inequity?, OXFORD UNIV PRESS, ISSN:1101-1262